Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Lewington, S, Clarke, R
Formato:	Journal article
Lenguaje:	English
Publicado:	2005

Ejemplares similares

Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk.
por: Lewington, S, et al.
Publicado: (2005)

Total cholesterol, arterial stiffness, and systolic blood pressure: a mediation analysis
por: Haojia Chen, et al.
Publicado: (2021-01-01)

Blood pressure, cholesterol and premature death
por: Lewington, S, et al.
Publicado: (1999)

Regression dilution bias in blood total and high-density lipoprotein cholesterol and blood pressure in the Glostrup and Framingham prospective studies.
por: Lewington, S, et al.
Publicado: (2003)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
por: Rao, S, et al.
Publicado: (2023)

The importance of cholesterol, blood pressure and smoking for coronary heart disease.
por: Lewington, S
Publicado: (2003)

Genetically predicted differences in systolic blood pressure and risk of cardiovascular and noncardiovascular diseases: a Mendelian randomization study in Chinese adults
por: Clarke, R, et al.
Publicado: (2023)

Stroke, coronary heart disease, cholesterol and blood pressure
por: Lewington, S, et al.
Publicado: (1997)

Differential effects of the changes of LDL cholesterol and systolic blood pressure on the risk of carotid artery atherosclerosis
por: Chien Kuo-Liong, et al.
Publicado: (2012-08-01)

Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age.
por: Clarke, R, et al.
Publicado: (2002)

Cigarette Smoking, Systolic Blood Pressure, and Cardiovascular Diseases in the Asia-Pacific Region
por: Nakamura, K, et al.
Publicado: (2008)

The value of earlier-in-life systolic and diastolic blood pressure for cardiovascular risk prediction
por: Andreas Leiherer, et al.
Publicado: (2024-03-01)

P.059 IS INCREASED SYSTOLIC BLOOD PRESSURE THE MAIN REASON FOR CARDIOVASCULAR DISEASES?
por: Z. Melik, et al.
Publicado: (2007-08-01)

Association between systolic interarm differences in blood pressure and cardiovascular disease outcomes and mortality
por: Clark, CE, et al.
Publicado: (2020)

Prediction of cardiovascular events from systolic or diastolic blood pressure
por: Atefeh Talebi, et al.
Publicado: (2022-06-01)

Total flying hours and risk of high systolic blood pressure in the civilian pilot in Indonesia
por: Ferdi Afian, et al.
Publicado: (2016-07-01)

Total flying hours and risk of high systolic blood pressure in the civilian pilot in Indonesia
por: Ferdi Afian, et al.
Publicado: (2016-07-01)

Systolic blood pressure and cardiovascular risk in patients with diabetes: a prospective cohort study
por: Rao, S, et al.
Publicado: (2022)

Binary cutpoint and the combined effect of systolic and diastolic blood pressure on cardiovascular disease mortality: A community-based cohort study.
por: Ju-Yeun Lee, et al.
Publicado: (2022-01-01)

Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?
por: Tapela, NM, et al.
Publicado: (2021)

Association between systolic blood pressure and low-density lipoprotein cholesterol with coronary heart disease according to age.
por: Nelson Wang, et al.
Publicado: (2023-01-01)

Blood pressure, cholesterol, and common causes ol death: A review
por: Lewington, S, et al.
Publicado: (1999)

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Chenxi Huang, et al.
Publicado: (2017-11-01)

Effect of eprosartan-based therapy on systolic blood pressure and total cardiovascular risk in a large international population: preliminary report of the observational POWER study
por: Goudev A, et al.
Publicado: (2012-09-01)

Homocysteine, renal function, and risk of cardiovascular disease.
por: Clarke, R, et al.
Publicado: (2003)

Comparison between clinic and home measurements of blood pressure, total cholesterol, blood sugar to identify 10-year atherosclerotic cardiovascular disease risk score
por: Putri Ani Sunjaya, et al.
Publicado: (2021-03-01)

Blood pressure, cholesterol, and common causes of death: a review. Prospective Studies Collaboration.
por: Lewington, S, et al.
Publicado: (1999)

Effects of within-person variability in spot urinary sodium measurements on associations with blood pressure and cardiovascular disease
por: Re, F, et al.
Publicado: (2021)

Combined effect of inter-arm systolic blood pressure difference and carotid artery plaque on cardiovascular diseases and mortality: A prospective cohort study
por: Cuijuan Yun, et al.
Publicado: (2022-11-01)

Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
por: Nakamura, K, et al.
Publicado: (2009)

Effect of Low Diastolic Blood Pressure to Cardiovascular Risk in Patients With Ischemic Stroke or Transient Ischemic Attacks Under Different Systolic Blood Pressure Levels
por: Zimo Chen, et al.
Publicado: (2020-05-01)

APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
por: Barry I. Freedman, et al.
Publicado: (2017-07-01)

The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of this preferential target
por: Jean-Jacques Mourad
Publicado: (2008-12-01)

Systolic blood pressure and risk of valvular heart disease: A mendelian randomization study
por: Nazarzadeh, M, et al.
Publicado: (2019)

Systolic blood pressure and vascular disease in men aged 65 years and over: the HIMS (Health in Men Study)
por: Lacey, B, et al.
Publicado: (2017)

Evaluating Sex Differences in the Effect of Increased Systolic Blood Pressure on the Risk of Cardiovascular Disease in Asian Populations: A Systematic Review and Meta-Analysis
por: Yu-Ting Lin, et al.
Publicado: (2022-10-01)

Blood pressure-lowering treatment lowers mortality and cardiovascular disease risk, but whether effects differ at an arbitrary threshold of 140 mm Hg systolic blood pressure requires further research
por: Canoy, D, et al.
Publicado: (2018)

Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
por: Clarke, R, et al.
Publicado: (2007)

Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population
por: Yu Yu, et al.
Publicado: (2022-10-01)

Homocysteine and risk of cardiovascular disease and venous thrombosis
por: Clarke, R, et al.
Publicado: (2003)